Tetyana Shvydko, PhD

Tetyana Shvydko specializes in applied microeconomics, antitrust economics, and econometrics. She conducts economic and statistical analyses of competition, market definition and market power in antitrust matters, with a particular emphasis on the healthcare industry. She has analyzed class certification and liability issues, and has performed damages estimation for major engagements in various industries, including healthcare, aerospace, dairy, and pharmaceuticals. Dr. Shvydko also has worked on engagements in the areas of products liability (asbestos) and employment discrimination. She has been published in the Industrial and Labor Relations Review.

PhD, Economics, University of North Carolina at Chapel Hill

MA, Economics (with honors), National University of Kyiv-Mohyla Academy, Ukraine

BS, Biology (with honors), National University of Kyiv-Mohyla Academy, Ukraine

• On behalf of Optum, supported the expert in work to clear Optum’s acquisition of Beaver Medical Group in Southern California before the Federal Trade Commission. Assisted with second request compliance as well as advocacy submissions addressing antitrust concerns.
• On behalf of the defendant and the intervenor in 21st Century Oncology v. State of Florida and Dr. Michael Katin (US District Court for the Northern District of Florida), supported the expert’s analysis regarding the economic literature on high concentration in the supply of physician services in geographic areas corresponding with or similar to counties.
• On behalf of UnitedHealth’s health services subsidiary Optum in its acquisition of DaVita Medical Group, assisted the expert with presentations and submissions to the Federal Trade Commission and several state Attorney General offices addressing potential horizontal and vertical concerns arising from the proposed transaction.
• Supported the expert on behalf of Wake Forest University Baptist Medical Center in assessing likely competitive effects of Wake Forest's proposed acquisition of High Point Regional Health. 
• On behalf of Humana in connection with its proposed merger with Aetna, provided support for responses to the Department of Justice’s second request, analyzed likely competitive effects and barrier to entry and exit in the sale of Medicare Advantage products, and analyzed likely competitive effects in the sale of individual health insurance on public exchanges.
• Supporting the consulting expert to the Massachusetts Health Policy Commission (HPC), an agency created in 2012 to increase value and access in the delivery of healthcare. 
• In Federal Trade Commission v. St. Luke’s Health System, Ltd., led economic analysis in support of the expert work of Professor David Dranove on behalf of the FTC and the State of Idaho. 
• Played a key role in developing the firm’s methodologies for using regression analysis to distinguish nuisance settlements from those corresponding to liability for asbestos-related personal injury claims on behalf of the Debtors in In re Specialty Products Holding Corp.
• In First American CoreLogic, Inc. v. Fiserv, Inc., supported testifying expert retained by a group of defendants to analyze the validity of a patent held by CoreLogic for econometric procedures used to estimate residential property values based on various known property characteristics.
• Supported expert retained by the UnitedHealth Group to analyze the competitive effects of its separate acquisitions of several local health insurers in the Medicare Advantage sector.
• In Sheridan Healthcorp, Inc. v. AvMed Inc., supported testifying expert in the analysis of market definition, market power, and competitive effects on behalf of AvMed Health Plans, a Florida health insurer. 
• In In re Delta/AirTran Baggage Fee Antitrust Litigation, supported testifying expert in economic and econometric analyses of class certification issues and damages on behalf of defendant AirTran in connection with an alleged conspiracy to reduce capacity in Atlanta and introduce a first-bag fee.